focus -WSS

focus

author：comprehensive 2025-09-06 02:13:02 - browse：2

A hand in pink glove holds a blue rack that contains three tubes of blood samples — first opinion coverage from STAT — Joe Raedle/Getty Images

During my 25 years working in clinical trial operations, I’ve seen the biopharmaceutical world talk a big game about making the process easier for the sites running the trials and the patients participating in them. Everyone from trial sponsors to the Food and Drug Administration has been quick to promise simpler processes, less hassle, and better experiences for everyone involved.

But look closer, and you’ll see that these grand promises often fall apart when sponsors implement complicated plans for collecting blood, tissue and other biospecimens and impossible processes for managing those samples. Behind all the talk and regulatory guidance, there’s a reluctance to change how these essential elements of clinical trial execution are handled, putting the very ideals that sponsors are trying to uphold at risk.

The concept of site and patient centricity frequently gets reduced to addressing only superficial gestures, such as committing to promptly paying sites for their work or using tablets for conducting patient surveys. But the essence of centricity extends far beyond these surface-level measures. It lies in addressing the unseen and unmentioned complexities of clinical trials and providing real solutions that focus on truly prioritizing the needs of trial sites and participants.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Novo acquires Inversago for up to $1 billion

WSS

Biotech startup Celsius cuts 75% of staff ahead of first trial start

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

FDA scientists endorse Pfizer/BioNTech Covid

The perfect storm of weather conditions that led to the devastating wildfires in Maui

Who is Jack Smith, the special counsel overseeing the DOJ's Trump probes?

How I helped Pfizer think through the ethics of Viagra

hotspot

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

hotspot

Hollywood unions extend contract negotiations for actors

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

Duchenne breakthrough therapy leaves behind pioneering families

Listen: Your guide to Wegovy's blockbuster heart study

What does generative AI mean for health care? We asked experts

How to ethically and practically extend health care to all

Medicare proposal to cover medical devices draws a mixed reaction

Newly revealed memo details efforts to keep Trump in power following election loss

How one medical school became remarkably diverse

Alnylam reports growth in sales of rare disease treatments

entertainment

Pharma budget tightening trickles down to Doximity

White House drug shortages task force keeps mum with Congress

Genentech weighs delaying cancer therapy after drug pricing law

Flint parents haunted by uncertainty, fears of lead poisoning

Personalized medicine goes far beyond genetics

2 officers injured in shooting in Orlando, police say

focus

entertainment

Wikipedia

entertainment